跳至主要内容
临床试验/NCT02009124
NCT02009124撤回2 期

Open Label Study of Autologous Bone Marrow Mononuclear Cells in Spinal Cord Injury

Neurogen Brain and Spine Institute2 个研究点 分布在 1 个国家开始时间: 2012年8月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
撤回
试验地点
2
主要终点
Change in clinical symptoms of spinal cord injury after 6 months

研究概览

简要总结

The purpose of this study is to study the effect of stem cell therapy on common symptoms in patients with spinal cord injury.

详细描述

Autologous bone marrow mononuclear cells are administered intrathecally by a standard procedure followed by vigorous rehabilitation therapy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Months 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed cases of any type of spinal cord injury
  • age above 12 months.

排除标准

  • presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus
  • malignancies
  • bleeding tendencies
  • pneumonia
  • renal failure
  • severe liver dysfunction
  • severe anemia [Hemoglobin < 8]
  • any bone marrow disorder
  • space occupying lesion in brain
  • other acute medical conditions such as respiratory infection and pyrexia.

研究组 & 干预措施

Stem cell

Experimental

autologous bone marrow mononuclear cell transplantation

干预措施: Autologous bone marrow mononuclear cell transplantation (Biological)

Control

No Intervention

Stem cell therapy is not done for this group of spinal cord injury patients

结局指标

主要结局

Change in clinical symptoms of spinal cord injury after 6 months

时间窗: 6 months

次要结局

  • Functional independence measure (FIM)(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验